131 related articles for article (PubMed ID: 37148070)
1. Use of Denosumab and Serial Arterial Embolization Combination Therapy as an Alternative to Surgical Resection in a Case of Large Sacro-Pelvic Giant Cell Tumor.
Gupta K; Jain AP; Ahuja K; Mittal S; Kandwal P
Neurol India; 2023; 71(2):345-348. PubMed ID: 37148070
[No Abstract] [Full Text] [Related]
2. Combining of serial embolization and denosumab for large sacropelvic giant cell tumor: Case report of 3 cases.
Ji T; Yang Y; Wang Y; Sun K; Guo W
Medicine (Baltimore); 2017 Aug; 96(33):e7799. PubMed ID: 28816971
[TBL] [Abstract][Full Text] [Related]
3. The multidisciplinary management of giant cell tumor of bone.
Ng VY; Davidson DJ; Kim EY; Pollack SM; Conrad Iii EU; Jones RL
Expert Rev Anticancer Ther; 2014 Jul; 14(7):783-90. PubMed ID: 24666240
[TBL] [Abstract][Full Text] [Related]
4. Denosumab in giant cell tumour of bone in the pelvis and sacrum: Long-term therapy or bone resection?
Sambri A; Medellin MR; Errani C; Campanacci L; Fujiwara T; Donati D; Parry M; Grimer R
J Orthop Sci; 2020 May; 25(3):513-519. PubMed ID: 31155442
[TBL] [Abstract][Full Text] [Related]
5. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.
Tsukamoto S; Tanaka Y; Mavrogenis AF; Kido A; Kawaguchi M; Errani C
Clin Orthop Relat Res; 2020 May; 478(5):1076-1085. PubMed ID: 31794487
[TBL] [Abstract][Full Text] [Related]
6. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
[TBL] [Abstract][Full Text] [Related]
7. Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.
Rutkowski P; Ferrari S; Grimer RJ; Stalley PD; Dijkstra SP; Pienkowski A; Vaz G; Wunder JS; Seeger LL; Feng A; Roberts ZJ; Bach BA
Ann Surg Oncol; 2015 Sep; 22(9):2860-8. PubMed ID: 26033180
[TBL] [Abstract][Full Text] [Related]
8. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
[TBL] [Abstract][Full Text] [Related]
9. Current management of giant-cell tumor of bone in the denosumab era.
Nagano A; Urakawa H; Tanaka K; Ozaki T
Jpn J Clin Oncol; 2022 May; 52(5):411-416. PubMed ID: 35199172
[TBL] [Abstract][Full Text] [Related]
10. Denosumab Does Not Decrease Local Recurrence in Giant Cell Tumor of Bone Treated With En Bloc Resection.
Tsukamoto S; Mavrogenis AF; Tanaka Y; Kido A; Kawaguchi M; Errani C
Orthopedics; 2021; 44(6):326-332. PubMed ID: 34618637
[TBL] [Abstract][Full Text] [Related]
11. A nonrandomized controlled study of sacral giant cell tumors with preoperative treatment of denosumab.
Yang Y; Li Y; Liu W; Xu H; Niu X
Medicine (Baltimore); 2018 Nov; 97(46):e13139. PubMed ID: 30431583
[TBL] [Abstract][Full Text] [Related]
12. Giant cell tumour of bone in the denosumab era.
van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
[TBL] [Abstract][Full Text] [Related]
13. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
Perrin DL; Visgauss JD; Wilson DA; Griffin AM; Abdul Razak AR; Ferguson PC; Wunder JS
Bone Joint J; 2021 Jan; 103-B(1):184-191. PubMed ID: 33380180
[TBL] [Abstract][Full Text] [Related]
14. Recurrent giant cell tumour of the distal ulna after en bloc resection with preoperative denosumab use.
Fujihara N; Hamada S; Yoshida M; Tsukushi S
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764115
[TBL] [Abstract][Full Text] [Related]
15. Giant cell tumor of the ischium: Imaging findings before and after neoadjuvant denosumab.
Tordjman M; Larousserie F; Mompoint D; Biau D; Lebreton C; Carlier RY
Diagn Interv Imaging; 2017 May; 98(5):447-450. PubMed ID: 28377083
[No Abstract] [Full Text] [Related]
16. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
[TBL] [Abstract][Full Text] [Related]
17. Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis.
Yayan J
Cancer Control; 2020; 27(3):1073274820934822. PubMed ID: 32869648
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
Rekhi B; Verma V; Gulia A; Jambhekar NA; Desai S; Juvekar SL; Bajpai J; Puri A
Pathol Oncol Res; 2017 Jan; 23(1):157-164. PubMed ID: 27722984
[TBL] [Abstract][Full Text] [Related]
19. [Treatment progress on giant cell tumors of bone].
Liang P
Zhongguo Gu Shang; 2018 Mar; 31(3):292-296. PubMed ID: 29600686
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Denosumab Therapy Against Giant Cell Tumor of Bone is Associated with an Increased Risk of Local Recurrence After Curettage Surgery.
Asano N; Saito M; Kobayashi E; Morii T; Kikuta K; Watanabe I; Anazawa U; Takeuchi K; Suzuki Y; Susa M; Nishimoto K; Ishii R; Miyazaki N; Mrioka H; Kawai A; Horiuchi K; Nakayama R
Ann Surg Oncol; 2022 Jun; 29(6):3992-4000. PubMed ID: 35175454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
